By treating DNA as a language, Brian Hie’s “ChatGPT for genomes” could pick up patterns that humans can’t see, accelerating ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discu ...

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $40.49, marking a +1.23% move from the previous day.

By creating gene editors not found in nature, or optimizing existing editors, AI can improve the accuracy, effectiveness, and accessibility of gene editing.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

Potent in vivo gene editing in skeletal muscle of non-human primates by a novel, ultracompact CRISPR system delivered via a single AAV vector.

NanoCas, an ultracompact nuclease, enables efficient muscle editing in NHPs using a single AAV - advancing gene editing for hard-to-target tissues.

In the rapidly evolving field of genetic engineering, few names resonate as profoundly as George Church, a geneticist at Harvard University. Known for his groundbreaking work in genomics, Church has ...

Liposuction and plastic surgery aren't often mentioned in the same breath as cancer.But they are the inspiration for a new ...

Deregulating New Zealand's gene tech space has been long-desired, but critics say the Government's growth-focused approach goes too far and risks too much, reports Fox Meyer ...

The global liquid biopsy tube market exhibits promising growth prospects, driven by advancements in cancer diagnostics and the increasing prevalence of ...